Inventor

Xenia B. Searle

Inventor
Grayslake, IL, US

Overview

20→
Patents
2005–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds14%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
10,988,454Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202110,981,890Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202110,844,041Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202010,844,042Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202010,829,473Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use202010,428,017Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use201910,399,940Substituted pyrrolidines and methods of use201910,118,916Modulators of cystic fibrosis transmembrane conductance regulator protein20189,981,910Substituted pyrrolidines and methods of use20189,840,513'Substituted tricyclics and method of use'20179,642,831'Substituted chromanes and method of use'20179,567,322'Substituted tetrahydropyrans and method of use'20178,796,470'Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators'20148,691,865'Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers'20148,129,417'Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers'20127,737,159'Antibacterial compounds'20107,196,200'Antibacterial compounds'20077,135,484'Azabicyclic compounds are central nervous system active agents'20067,030,262'3-Amino-2-hydroxyalkanoic acids and their prodrugs'20066,887,863'Hydrazide and alkoxyamide angiogenesis inhibitors'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2012Patents assigned to ABBOTT LAB (6)· patent assignee history
2005–2021Based in Grayslake, IL, US· patent location history
2017–2021Patents assigned to GALAPAGOS NV (12)· patent assignee history
2017Patents assigned to ABBVIE S Á R L (3)· patent assignee history
2018–2019Patents assigned to ABBVIE SARL (4)· patent assignee history
2020–2021Patents assigned to ABBVIE OVERSEAS SARL (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GALAPAGOS NV122017–2021
ABBOTT LAB62005–2012
ABBVIE OVERSEAS SARL52020–2021
ABBVIE SARL42018–2019
ABBVIE S Á R L32017
Locations
LocationPatentsSpan
Grayslake, Illinois, US202005–2021